| Literature DB >> 21829467 |
Theresa Casey1, Heather Dover, James Liesman, Lindsey DeVries, Matti Kiupel, Michael Vandehaar, Karen Plaut.
Abstract
Transcriptome analysis of bovine mammary development has provided insight into regulation of mammogenesis. However, previous studies primarily examined expression of epithelial and stromal tissues combined, and consequently did not account for tissue specific contribution to mammary development. Our objective was to identify differences in gene expression in epithelial and intralobular stromal compartments. Tissue was biopsied from non-lactating dairy cows 3 weeks prepartum, cut into explants and incubated for 2 hr with insulin and hydrocortisone. Epithelial and intralobular stromal tissues were isolated with laser capture microdissection. Global gene expression was measured with Bovine Affymetrix GeneChips, and data were preprocessed using RMA method. Moderated t-tests from gene-specific linear model analysis with cell type as a fixed effect showed more than 3,000 genes were differentially expressed between tissues (P<0.05; FDR<0.17). Analysis of epithelial and stromal transcriptomes using Database for Annotation, Visualization and Integrated Discovery (DAVID) and Ingenuity Pathways Analysis (IPA) showed that epithelial and stromal cells contributed distinct molecular signatures. Epithelial signatures were enriched with gene sets for protein synthesis, metabolism and secretion. Stromal signatures were enriched with genes that encoded molecules important to signaling, extracellular matrix composition and remodeling. Transcriptome differences also showed evidence for paracrine interactions between tissues in stimulation of IGF1 signaling pathway, stromal reaction, angiogenesis, neurogenesis, and immune response. Molecular signatures point to the dynamic role the stroma plays in prepartum mammogenesis and highlight the importance of examining the roles of cell types within the mammary gland when targeting therapies and studying mechanisms that affect milk production.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21829467 PMCID: PMC3146472 DOI: 10.1371/journal.pone.0022541
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Images of the mammary tissue captured to document cell types captured with laser capture microdissection.
Images were captured using light microscopy at 200X A) prior to laser capture microdissection (LCM) B) following LCM and of the C) cap to document populations of epithelial cells isolated from slide.
Summary of number of genes differentially expressed at P-value cut-off and associated maximal FDR.
| Higher in stroma | Higher in epithelium | |||
| P-value | no. | max. FDR | no. | max. FDR |
| 0.05 | 1108 | 0.16 | 1993 | 0.16 |
| 0.01 | 761 | 0.05 | 1016 | 0.05 |
| 0.001 | 487 | 0.01 | 394 | 0.01 |
Representative gene sets within the functional groups significantly enriched (P<0.0001) with genes expressed at a greater level in epithelial or stromal tissue and identified using Functional Annotation Clustering in NIH DAVID.
| Gene set | Score | No. |
| Epithelial | ||
| GOTERM_CC_ALL:GO:0005737∼cytoplasm | 28.37 | 332 |
| GOTERM_BP_ALL:GO:0009058∼biosynthetic process | 20.23 | 140 |
| GOTERM_BP_ALL:GO:0044267∼cellular protein metabolic process | 14.17 | 189 |
| GOTERM_CC_ALL:GO:0031090∼organelle membrane | 10.91 | 74 |
| GOTERM_CC_ALL:GO:0005739∼mitochondrion | 7.95 | 83 |
| GOTERM_CC_ALL:GO:0031410∼cytoplasmic vesicle | 5.07 | 28 |
| GOTERM_CC_ALL:GO:0033279∼ribosomal subunit | 4.65 | 16 |
| Stromal | ||
| GOTERM_CC_ALL:GO:0031012∼extracellular matrix | 12.27 | 28 |
| GOTERM_BP_ALL:GO:0007155∼cell adhesion | 10.52 | 32 |
| SP_PIR_KEYWORDS:signal | 7.96 | 93 |
| GOTERM_BP_ALL:GO:0007275∼multicellular organismal development | 4.86 | 44 |
| GOTERM_BP_ALL:GO:0009611∼response to wounding | 4.56 | 22 |
| GOTERM_BP_ALL:GO:0009611∼response to wounding | 4.56 | 22 |
*Score is DAVID's enrichment score, the –log of the median P-value for the functional group.
Figure 2Molecular and cellular function ontologies enriched with genes expressed at greater level in epithelial and stromal tissues.
Ontologies more highly enriched by genes expressed at greater level in A) epithelial and B) stromal tissue in mammary glands of three week prepartum dry cows generated using IPA. Y-axis = −log (P-value).
Figure 3Cellular distribution of gene products expressed in epithelial and stroaml tissue.
Genes expressed at a greater level in A) epithelium and B) intralobular stroma of dry cows three weeks prepartum.
Biological functions of genes in the top 5 networks generated in IPA; (scores) and [central molecules] within networks.
| Higher in epithelium | Higher in stroma |
| Protein synthesis, transcription, translation, cytoskeletal (49) [FOS] | Tissue development, extracellular matrix (51) [NID/Laminins] |
| RNA post-transcriptional modification, cellular assembly and organization, DNA replication, recombination and repair (46) [WBP4, MAPK] | Tissue morphology, inflammation (44) [IL6] |
| Protein synthesis RNA post-transcriptional modification, gene expression (38) | Cellular assembly and organization, cellular function and maintenance and cell movement (37) [dynamin] |
| Gene expression, cell movement, cell to cell signaling and interaction (38) [MR124] | Cell-to-cell signaling and interaction, cell-ECM interaction (36) [TGFBR2, integrins, collagens] |
| Secretory activity, mitochondrial respiration (36) [RIF1] | Cell death/survival, extracellular matrix (36) [FN1] |
Canonical pathways enriched with genes expressed higher in epithelial or stromal tissue.
| Canonical Pathway | Score | Ratio† |
| Epithelial | ||
| Protein ubiquitination pathway | 3.7 | 0.17 |
| Oxidative phosphorylation | 3.4 | 0.16 |
| Clathrin-mediated endocytosis signaling | 2.5 | 0.15 |
| Mitochondrial dysfunction | 2.2 | 0.14 |
| P70S6K signaling | 2.1 | 0.15 |
| PPAR signaling | 2.0 | 0.15 |
| PI3K/AKT signaling | 2.0 | 0.14 |
| Renal Cell carcinoma signaling | 1.9 | 0.18 |
| Angiopoietin signaling | 1.9 | 0.17 |
| Aldosterone signaling in epithelial cells | 1.8 | 0.14 |
| Butonoate metabolism | 1.8 | 0.10 |
| IGF-1 signaling | 1.8 | 0.15 |
| Aryl hydrocarbon receptor signaling | 1.7 | 0.13 |
| LPS-stimulated MAPK signaling | 1.6 | 0.10 |
| Cell cycle: G2/M DNA damage check point regulation | 1.5 | 0.17 |
| 14-3-3 mediated signaling | 1.5 | 0.20 |
| Xenobiotic metabolism signaling | 1.5 | 0.15 |
| NRF2-mediated oxidative stress response | 1.5 | 0.10 |
| Citrate cycle | 1.5 | 0.12 |
| PDGF signaling | 1.5 | 0.11 |
| Neuregulin signaling | 1.5 | 0.12 |
| Stromal | ||
| Hepatic fibrosis/hepatic stellate activation | 11 | 0.20 |
| Dendritic cell maturation | 3.0 | 0.08 |
| Complement system | 2.6 | 0.18 |
| Leukocyte extravasation signaling | 2.5 | 0.09 |
| Virus entry via endocytic pathways | 2.5 | 0.10 |
| ILK signaling | 2.5 | 0.12 |
| Caveolar-mediated endocytosis signaling | 2.3 | 0.13 |
| Crosstalk between dendritic cells and natural killer cells | 2.2 | 0.18 |
| TREM1 signaling | 2.0 | 0.10 |
| Acute phase signaling | 1.8 | 0.08 |
| IL-6 signaling | 1.8 | 0.11 |
| NOTCH signaling | 1.8 | 0.12 |
| LXR/RXR Activation | 1.7 | 0.10 |
| Macropinocytosis signaling | 1.4 | 0.10 |
| Clathrin mediated endocytosis | 1.4 | 0.08 |
| Graft versus host disease signaling | 1.3 | 0.10 |
| IL-8 signaling | 1.3 | 0.08 |
| Actin cytoskeleton signaling | 1.3 | 0.06 |
*score = −log(P-value); †ratio = number of genes enriching set/total number of genes in set.
Figure 4Epithelial (shades of green) and stromal (shades of red) contributions to extracellular and plasma membrane signatures of the mammary transcriptome in three week prepartum dry cows.
Gene names, fold differences in expression, P-Value, and FDR are given in Supplemental Information S1, worksheet M.
Growth factors expressed at a greater level in epithelial or intralobular stromal cells.
| Symbol | Name | Fold change | P-value | FDR |
| Epithelial | ||||
| IL18 | interleukin 18 (interferon-gamma-inducing factor) | −2.586 | 2.60E-02 | 0.105 |
| SPP1 | secreted phosphoprotein 1 | −7.247 | 7.89E-03 | 0.048 |
| BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | −5.039 | 2.22E-04 | 0.004 |
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | −5.845 | 8.03E-03 | 0.049 |
| PLA2G12A | phospholipase A2, group XIIA | −3.235 | 2.77E-02 | 0.109 |
| SULF2 | sulfatase 2 | −3.567 | 5.00E-02 | 0.162 |
| BTC | betacellulin | −1.415 | 6.36E-03 | 0.042 |
| FGF2 | fibroblast growth factor 2 (basic) | −2.172 | 4.15E-02 | 0.143 |
| PDGFC | platelet derived growth factor C | −3.792 | 1.90E-03 | 0.018 |
| TGFB2 | transforming growth factor, beta 2 | −2.339 | 1.70E-02 | 0.08 |
| VEGFA | vascular endothelial growth factor A | −3.442 | 1.25E-03 | 0.013 |
| Stromal | ||||
| CCL14 | chemokine (C-C motif) ligand 14 | 7.457 | 1.95E-05 | 0.001 |
| CCL2 | chemokine (C-C motif) ligand 2 | 10.067 | 4.55E-07 | 0 |
| CCL21 | chemokine (C-C motif) ligand 21 | 3.652 | 1.86E-03 | 0.018 |
| CCL8 | chemokine (C-C motif) ligand 8 | 3.742 | 2.91E-03 | 0.024 |
| CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | 3.605 | 1.90E-02 | 0.086 |
| CSF1 | colony stimulating factor 1 (macrophage) | 3.67 | 6.13E-03 | 0.041 |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 3.817 | 1.26E-04 | 0.002 |
| CXCL16 | chemokine (C-X-C motif) ligand 16 | 2.804 | 1.07E-03 | 0.012 |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 7.308 | 4.19E-04 | 0.006 |
| FAM3C | family with sequence similarity 3, member C | 2.55 | 2.12E-02 | 0.092 |
| IL6 | interleukin 6 (interferon, beta 2) | 17.019 | 6.39E-05 | 0.001 |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 2.329 | 1.63E-02 | 0.078 |
| ANGPT2 | angiopoietin 2 | 8.661 | 2.60E-05 | 0.001 |
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 13.635 | 2.22E-06 | 0 |
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 8.739 | 6.37E-05 | 0.001 |
| JAG1 | jagged 1 (Alagille syndrome) | 3.844 | 8.17E-04 | 0.01 |
| KITLG | KIT ligand | 3.086 | 1.56E-04 | 0.003 |
| NOV | nephroblastoma overexpressed gene | 2.27 | 9.22E-03 | 0.054 |
| OGN | osteoglycin | 28.521 | 0.00E+00 | 0 |
| PTN | pleiotrophin | 2.125 | 1.79E-02 | 0.082 |
| VEGFC | vascular endothelial growth factor C | 6.419 | 3.78E-04 | 0.005 |
*Fold change is expressed as the difference between stromal-epithelial, thus the level of PDGFC expression is 3.79-fold greater in epithelial cells relative to intralobular stromal fibroblasts.
Figure 5Immunohistochiemical staining shows distribution of fibronectin and MMP3 protein in bovine mammary tissue three weeks prepartum.
Images of mammary explant tissue cultured for 2 hrs with insulin and hydrocortisone and captured using light microscopy at 200X following immunohistochemical staining with A) primary mouse polyclonal anti-MMP-3;B) primary mouse monoclonal anti-fibronectin antibody at RT or incubation with diluent alone for C) MMP 3 negative control, and D) fibronectin negative control, followed by incubation with a broad-spectrum secondary antibody conjugated with streptavidin-peroxidase that was visualized with incubation with 3′, 3′-diaminobenzidine chromogen substrate. All slides were counterstained with hematoxylin and cover-slipped before capture.